You have 9 free searches left this month | for more free features.

TMPRSS2

Showing 26 - 50 of 124

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Monoamine Oxidase Inhibitor on Phenotype of Blood Mononucleated

Recruiting
  • SARS-CoV2 Infection
  • blood sample
  • Le Kremlin-Bicêtre, France
    CHU Bicêtre
Dec 20, 2021

COVID-19 Trial (Optate, Placebo)

Not yet recruiting
  • COVID-19
  • (no location specified)
Apr 4, 2023

Covid19 Trial (Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone, The standard therapy)

Unknown status
  • Covid19
  • Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone
  • The standard therapy
  • (no location specified)
Nov 9, 2020

Intradermal Covid-19 Vaccine, Immungenicity and Safety, Immunocompromised Patients Trial in Hong Kong (ID BNT162b2 vaccine, IM

Recruiting
  • Intradermal Covid-19 Vaccine
  • +3 more
  • ID BNT162b2 vaccine
  • IM BNT162b2 vaccine
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Feb 19, 2023

COVID-19 Pneumonia Trial in Campinas, São Paulo (NestaCell®, Placebo)

Completed
  • COVID-19 Pneumonia
  • NestaCell®
  • Placebo
  • Campinas, São Paulo, Brazil
  • +3 more
Oct 26, 2022

COVID-19 Virus Infection Trial in Salvador (LCLT : 68% elemental L-carnitine and 32 % Tartric acid, Placebo)

Completed
  • COVID-19 Virus Infection
  • LCLT : 68% elemental L-carnitine and 32 % Tartric acid
  • Placebo
  • Salvador, Bahia, Brazil
    Senai Cimatec
Jun 30, 2022

SLPI for Prostate Cancer

Recruiting
  • Prostate Cancer
  • Prostatic Neoplasm
  • Secretory leukocyte protease inhibitor (SLPI) in prostate cancer
  • +2 more
  • Florence, Tuscany, Italy
    Careggi University Hospital
May 6, 2022

Past Coronavirus Disease 19 Infection on Live Birth Rates of

Not yet recruiting
  • COVID-19
  • Frozen Embryo Transfer
  • frozen embryo transfer
  • Shanghai, China
    ShangHai JIAI Genetics&IVF Institute
Feb 21, 2023

Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study

Withdrawn
  • COVID-19
    • (no location specified)
    Nov 1, 2022

    Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Melbourne (177Lu-PSMA)

    Recruiting
    • Prostate Cancer
    • Metastatic Castration-resistant Prostate Cancer
    • 177Lu-PSMA
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Mar 28, 2022

    SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill

    Active, not recruiting
    • COVID-19 Disease
    • Data collection from lumbar puncture
    • +3 more
    • Basel, Switzerland
      Neurosurgery, University Hospital Basel
    Nov 1, 2021

    Corona Virus Infection, SARS-CoV-2 Infection, SARS-CoV-2 PCR Test Positive Trial in Germany (biological, drug, other)

    Completed
    • Corona Virus Infection
    • +3 more
    • Convalescent plasma
    • +3 more
    • Freiburg im Breisgau, Baden-Württemberg, Germany
    • +5 more
    Feb 9, 2022

    Effect of Covid-19 Vaccination on Male

    Not yet recruiting
    • COVID-19 Pandemic
    • semen analysis and hormonal proflie
    • (no location specified)
    Mar 29, 2022

    Prostatic Adenocarcinoma and Its Clinicopathological Features

    Not yet recruiting
    • Prostate Adenocarcinoma
    • Immunohistochemistry of prostate biopsy
    • (no location specified)
    Mar 30, 2021

    COVID-19 Pneumonia Trial in Hong Kong (Bacillus subtilis)

    Completed
    • COVID-19 Pneumonia
    • Bacillus subtilis
    • Hong Kong, Hong Kong
      Zentrogene Bioscience Laboratory Ltd
    Dec 22, 2021

    Epidemiologic, Clinical and Molecular Characteristics of Acute

    Recruiting
    • Covid19
    • Patient with SAR-CoV-2 infection
    • Rozzano, Milan, Italy
      Humanitas Research Hospital
    Oct 17, 2022

    Healthy Trial (REGN7999, Placebo)

    Not yet recruiting
    • Healthy
    • (no location specified)
    Jul 28, 2022

    Corona Virus Infection Trial in Denmark, Sweden (Camostat Mesilate, Placebo oral tablet)

    Recruiting
    • Corona Virus Infection
    • Camostat Mesilate
    • Placebo oral tablet
    • Hjørring, Region Nord, Denmark
    • +10 more
    Apr 27, 2021

    Advanced Prostate Cancer Trial in Baltimore (Pelvic DCFPyL PET-MRI fusion or PET/MRI)

    Recruiting
    • Advanced Prostate Cancer
    • Pelvic DCFPyL PET-MRI fusion or PET/MRI
    • Baltimore, Maryland
      The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Mar 22, 2022

    COVID-19, Corona Virus Infection Trial in Sweden (Enzalutamide Pill)

    Terminated
    • COVID-19
    • Corona Virus Infection
    • Enzalutamide Pill
    • Malmö, Skåne, Sweden
    • +5 more
    May 30, 2022

    Covid19, SARS-CoV Infection, Coronavirus Infection Trial in Baltimore (Camostat Mesilate, Bicalutamide 150 mg)

    Terminated
    • Covid19
    • +2 more
    • Camostat Mesilate
    • Bicalutamide 150 mg
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Sep 15, 2021

    Prostate Cancer Trial in Vancouver, Toronto (Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab)

    Recruiting
    • Prostate Cancer
    • Apalutamide 60mg Tab
    • +5 more
    • Vancouver, British Columbia, Canada
    • +1 more
    May 25, 2022

    Metastatic Castration-Resistant Prostatic Cancer Trial in Belgium, Sweden (Enzalutamide Oral Capsule [Xtandi], Abiraterone Oral

    Recruiting
    • Metastatic Castration-Resistant Prostatic Cancer
    • Enzalutamide Oral Capsule [Xtandi]
    • +6 more
    • Aalst, Belgium
    • +22 more
    Sep 28, 2021

    Prostatic Tumors, Low Grade Prostate Cancer Trial in Quebec (Dietary intervention first, Drug (Dutasteride) intervention first)

    Active, not recruiting
    • Prostatic Neoplasms
    • Low Grade Prostate Cancer
    • Dietary intervention first
    • Drug (Dutasteride) intervention first
    • Quebec, Canada
    • +1 more
    Mar 14, 2022

    Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)

    Recruiting
    • Metastatic Hormone Naive Prostate Cancer
    • Sydney, New South Wales, Australia
    • +4 more
    Nov 4, 2022